GEN Compiles List of Top Selling Drugs for 2012


GENGenetic Engineering & Biotechnology News has compiled a list of the top 20 best-selling prescription drugs worldwide for 2012.  GEN's list, which the journal released on March 5 (see "Top 20 Best-Selling Drugs of 2012"), was based on sales figures obtained from biopharma company press announcements, annual reports, and conference calls during 2012 and 2011.  For each drug on its list, GEN has provided 2011 and 2012 sales, percent change from 2011 to 2012, and Q4 sales and percent change for both 2011 and 2012.  2012 sales for the top 20 drugs range from $3.81 billion to $9.265 billion.  GEN's top 20 rankings are shown below, with the additional designation of small molecule or biologic for each drug that made GEN's list.

Genetic Engineering & Biotechnology News Top 20 Best-Selling Drugs of 2012

Top 20 Drugs
Genetic Engineering & Biotechnology News, "Top 20 Best-Selling Drugs of 2012," March 5, 2013.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDonnell Boehnen Hulbert & Berghoff LLP | Attorney Advertising

Written by:


McDonnell Boehnen Hulbert & Berghoff LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.